IGI Logo

Below are Quote on Pharma companies by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd   

Pharma Majors- Cipla, Dr.Reddy’s, Sun pharma, Torrent pharma and Emcure are collaborating for the Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for treatment of mild COVID-19 patients in India.

Molnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2. This drug can be used for the patients who have tested positive for Covid 19 and non-hospitalized. The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise, and monitor the clinical trial in India. As per the directive of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization, Dr. Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr. Reddy’s in its clinical trial.

Though the covid cases in India are stabilizing at 50000 cases per day, the fear of 3^rd wave and Delta plus variants cannot be ruled out. This drug will help the mild cases of covid to be treated at home and decrease the requirement of hospitalization in such cases. This is positive for all the companies.

Above views are of the author and not of the website kindly read disclaimer